Robert Bellin, associate professor of biology at Holy Cross, is currently researching the causes of neurofibromatosis type-2 in a laboratory setting with his junior and senior students, a project he refers to as “a team effort.”
Bellin became interested in neurofibromatosis during a post-doctoral position at Boston Children’s Hospital after earning his Ph.D. in biochemistry from Iowa State University. He has conducted research on the disorder for 14 years.
Neurofibromatosis, also known as NF, refers to a broad range of inherited gene diseases that cause tumorous growths in different regions of the body. NF affects approximately 150,000 people worldwide.
Bellin’s research focuses specifically on NF Type-2 (NF-2), a form of the disease which causes non-malignant brain tumors that impair audio-visual perception. His studies focus on a protein within NF-2 cells called “merlin.” The exact nature of this gene is not entirely understood, but mutations of it are what seem to result in NF-2.
This is not Bellin’s only research project. In fact, he’s working on five more. With so many plates spinning in the air, he relies on his junior and senior students to carry some of the load. Much of the work into NF-2, “is done by my upper-level biology students,” he says. “They’ve been the ones who have often made some of the most significant developments.” The three most recent students to work with Bellin on the NF-2 project are Cat Flynn ’12, Mary Zabinski ’13 and, currently, Roy Gildersleeve ’14, all biology majors.
Flynn was involved in creating mutant forms of the merlin protein that match those in the human NF2 patient database, Zabinski tested those proteins by cell culture and confocal microscopy, and Gildersleeve is using those mutant forms of merlin to generate permanent cell-based models of NF2 in cell culture, which future students in the lab will use for continued studies.
With the support of a scientific grant from the school to fund their research, Bellin and his team have advanced their research for many years in a row, and are looking to sustain that momentum. While Bellin says that he’s, “not likely to find a cure or new treatment,” he hopes his team is able to make valuable contributions to the scientific community’s ongoing NF-2 research efforts.
Vannicelli Lecture by Jacob Medina '16See More > 04/10/2015
A Seussebration: Hats Off to 111 Years of Dr. SeussSee More > 04/15/2015
Lunch & Learn: LGBTQ Safe ZoneSee More > 04/17/2015
'Libertad' performed by The College Choir and Chamber SingersSee More >
‘The 50 Best Private Colleges for Earning Your Degree On Time’
According to Money, a subsidiary of TIME.com, the College of the Holy Cross ranks No. 12 in the top 50 best private colleges for earning your degree on time and No. 101 for...03/04/15
‘At Notre Dame, a door closes, but many more are opening across Catholic higher ed’
Wall Street Journal | The Conversation
Joanne Pierce, professor of religious studies at College of the Holy Cross and a University of Notre Dame alumna, reflects on the legacy of Rev. Theodore Hesburgh, president...02/18/15
‘Exploring an Institution’s Roots: Board Members Walk in a Saint’s Footsteps’
In the January/February issue of Trusteeship Magazine, Rev. Philip L. Boroughs, S.J., president of the College of the Holy Cross, reflects on the pilgrimage he led with a...